Undeniable, page-27

First 27 Last

Share
Profile

Follow
tdubs

141 Posts.

33

12/01/18

15:15

Post #: 30262265
Share

Originally posted by Kfann ↑

Hi all,

The revenue growth data from the US is what the risk managers have, historically, been concerned with. Will there be sufficient revenue growth/momentum to push the return on this US$30m investment undeniably and irreversibly to positive territory?

"Yes" is now the only possible answer.

I, like other PI's and fundies, will be awaiting the half yearly to update the empirical impact of this upon cash flow and balance sheet to assess the true quality of this growth.

But I'm pretty sure I'll just be confirming that the financial metrics are moving strongly in the right direction.

The next medium term goal that I'll be assessing this investment against are its share and technology leadership within the nascent 3D market; the execution of its competitive strategy.

Depending on how aggressive their marketing and pricing strategy is, I (and subject to some discussion with management/analysts) believe they could readily attain a US ACV of US$80-100m pa within 4 years; eclipsing my estimated Australiasian ACV of A$75-80m.

It is pure personal preference (not a science) in assigning valuation multiples to revenues and EBITDA....so I'll let you do yours.

Yet my models are suggesting a valuation range of A$670-830m within 2 years. A$1.60-A$2.00 fully diluted.

My gut, however, thinks this could be quite conservative.

Cheers,

Expand

Aggressive on the Aus ACV.

Cash burn was a lot higher than what the risk managers expected - they're getting revenue traction in the States but paying through the roof for it..

NEA Price at posting: 67.5¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Chaos reigns markets – so let's take stock of where we're at ahead of December

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

There are more pages in this discussion • 1 more message in this thread...

First 27 Last

Add NEA (ASX) to my watchlist

Undeniable, page-27

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Chaos reigns markets – so let's take stock of where we're at ahead of December

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025